|Other Accession||NM_032738, NP_116127|
|Alias Symbol||FCRL, FCRLM1, FCRLX, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FREB, MGC4595, RP11-474I16.5, FCRX, FCRL1|
|Other Names||Fc receptor-like A, Fc receptor homolog expressed in B-cells, Fc receptor-like and mucin-like protein 1, Fc receptor-like protein, Fc receptor-related protein X, FcRX, FCRLA, FCRL, FCRL1, FCRLM1, FCRX, FREB|
|Format||Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.|
|Reconstitution & Storage||Add 50 ul of distilled water. Final anti-FCRLA antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles.|
|Precautions||FCRLA antibody - C-terminal region is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||FCRL, FCRL1, FCRLM1, FCRX, FREB|
|Function||May be implicated in B-cell differentiation and lymphomagenesis.|
|Cellular Location||Cytoplasm Note=Seems not to be secreted.|
|Tissue Location||Expressed specifically in primary and secondary lymphoid tissues like lymph node, spleen and tonsil Specifically expressed in B-cells with a high level in normal germinal center B-cells, centroblasts and in a subset of diffuse large B-cell lymphomas. Highly expressed in bone marrow B-cells and weakly in earlier B lineage cells. Expressed in pre-germinal and germinal center B-cells in secondary lymphoid tissues. Also expressed in melanoma and melanocytes|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Mechetina L.V.,et al.Eur. J. Immunol. 32:87-96(2002).
Facchetti F.,et al.Proc. Natl. Acad. Sci. U.S.A. 99:3776-3781(2002).
Davis R.S.,et al.Int. Immunol. 14:1075-1083(2002).
Inozume T.,et al.Int. J. Cancer 114:283-290(2005).
Guselnikov S.,et al.Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.